Menu

Experience

Barbara Borden

    • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 


    • Meredith Agrees to Sell National Media Group to IAC’s Dotdash 


    • ZOLL Medical Agrees to Acquire Itamar Medical for $538 Million 


    • Vividion Therapeutics Agrees to Sell to Bayer for up to $2 Billion 


    • Prothena Agrees to Sell ATTR Amyloidosis Program to Novo Nordisk 


    • Horizon Therapeutics to Acquire Viela Bio 


    • VelosBio Agrees to Sell to Merck for $2.75 Billion 


    • Forbius Agrees to Sell to Bristol Myers Squibb 


    • Synthorx to Sell to Sanofi for $2.5 Billion 


    • Avedro Sells to Glaukos 


    • Arlo to Partner with Verisure 


    • Jazz Pharmaceuticals Acquisition of Redx Pharma's pan-RAF Inhibitor Program Valued up to $206 Million 


    • SendGrid Sells to Twilio for $2 Billion 


    • BroadSoft Sells to Cisco for $1.9 Billion 


    • Sucampo Sells to Mallinckrodt for $1.2 Billion 


    • EnerNOC Sells to Enel Group for More Than $300 Million 


    • Horizon Pharma Buys River Vision for $145 Million and Unspecified Earn-Out 


    • ZELTIQ Aesthetics to Sell to Allergan for $2.5 Billion 


    • Jazz Pharmaceuticals Acquires Celator for $1.5 Billion 


    • Horizon Pharma Acquisition of Crealta Holdings for $510 Million 


    • Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb 


    • NetScout Receives DOJ Clearance After Second Request in $2.6 Billion Acquisition 


    • Auspex Pharma $3.5 billion sale to Teva Pharma 


    • Auspex Pharma Acquired by Teva for $3.5 Billion 


    • Horizon Pharma Acquires Hyperion Therapeutics for $1.1 Billion 


    • CardioKinetix Completes $50 Million Financing 


    • Volcano Corp. Acquired by Royal Philips NV for $1.2 Billion 


    • Volcano Acquired by Philips for $1.2 Billion 


    • NetScout Systems to Acquire Danaher Communications Business for $2.6B 


    • Ambit Biosciences to be Acquired by Daiichi Sankyo for $410 Million 


    • Horizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility 


    • Horizon Pharma $660 Million Acquisition of Vidara Therapeutics 


    • Horizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility 


    • Coverity $375 Million Acquisition by Synopsys 


    • Trius Therapeutics Acquisition by Cubist Pharmaceuticals 


    • Websense $1 Billion Acquisition by Vista Equity 


    • Hot Topic $600 Million Sale to Sycamore Partners